Nephro Care India Limited has announced the incorporation of a new subsidiary company as part of its long-term growth and expansion strategy in the healthcare sector. The development was formally disclosed to the National Stock Exchange on December 19, 2025, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, highlighting the company’s continued focus on strengthening its presence across multiple healthcare verticals.

According to the regulatory filing, the Ministry of Corporate Affairs has approved and issued the Certificate of Incorporation for the subsidiary named Vivacity Multiple Ventures Private Limited on December 18, 2025. With this approval, Vivacity Multiple Ventures Private Limited has officially become a subsidiary of Nephro Care India Limited, marking an important milestone in the company’s corporate development journey. This announcement has drawn attention in Nephro Care India Limited news, especially among investors tracking expansion-led strategies in the healthcare space.

Vivacity Multiple Ventures Private Limited has been incorporated in Kolkata, West Bengal, and is registered with the Registrar of Companies, Kolkata. As per the disclosure, the subsidiary is yet to commence its business operations, and its turnover currently stands at nil. However, the newly formed entity has been created with a broad and ambitious set of objectives that align closely with Nephro Care India’s core healthcare focus.

The subsidiary will operate within the healthcare sector, with a wide scope of activities covering hospitals, nursing homes, diagnostic centres, clinics, laboratories and allied medical facilities. The objects of the subsidiary include running, managing, administering and establishing diagnostic centres, CT scan centres, nursing homes, hospitals, clinics, dispensaries, maternity homes, and mental healthcare centres. It also plans to engage in clinical pathological testing laboratories, X-ray and ECG clinics, and consultancy services related to healthcare infrastructure and operations.

This strategic move is significant in the context of Nephro Care India latest news, as it reflects the company’s intent to diversify and scale its healthcare offerings beyond its existing focus areas. The subsidiary’s objectives also include establishing and operating medical institutions such as medical, veterinary and dental colleges, along with providing technical know-how, advisory services and operational support for healthcare facilities in India and overseas.

One of the most notable aspects of Vivacity Multiple Ventures Private Limited is its emphasis on comprehensive medical care. The subsidiary’s charter includes facilities for the treatment and rehabilitation of patients, management of kidney disease care, and development of therapies across various medical disciplines. This aligns strongly with Nephro Care India’s established expertise in nephrology and renal care, enabling potential synergies between the parent company and the subsidiary.

From a financial standpoint, Nephro Care India Limited has acquired a 51% equity stake in the subsidiary, making Vivacity Multiple Ventures Private Limited a subsidiary and related party under SEBI Listing Regulations. The cost of acquisition for this stake is Rs 5.10 lakh, representing 51,000 equity shares of Rs 10 each. The consideration for the acquisition has been made in cash, as disclosed in the annexure accompanying the regulatory filing.

The disclosure clarifies that the incorporation of the subsidiary does not require any specific governmental or regulatory approvals, apart from the routine incorporation approval granted by the Ministry of Corporate Affairs. Additionally, since the transaction involves incorporation rather than acquisition of an existing business, there is no indicative time period for completion, as the process has already been concluded with the issuance of the incorporation certificate.

The move to establish a subsidiary rather than directly expanding operations under the parent entity provides Nephro Care India with greater operational flexibility and strategic focus. Subsidiaries allow companies to pursue new business lines, partnerships and geographic expansions while managing risks independently. This structure is particularly relevant in the healthcare sector, where regulatory requirements, capital intensity and operational complexities often vary across services and locations.

In the broader context of healthcare sector corporate news, the incorporation of Vivacity Multiple Ventures Private Limited reflects a growing trend among listed healthcare companies to build integrated platforms covering diagnostics, hospitals, specialised treatment centres and allied services. With rising healthcare demand, increasing awareness, and growing emphasis on quality medical infrastructure, such expansion initiatives are seen as critical for long-term growth.

The subsidiary’s detailed object clause also highlights its intent to establish and manage research centres, operation theatres, chemist shops, blood banks, eye banks, kidney banks, physiotherapy centres and investigation centres. This comprehensive scope underscores the ambition to create a diversified healthcare ecosystem capable of serving a wide range of medical needs under one corporate umbrella.

From a regulatory and governance perspective, the timely disclosure under Regulation 30 of SEBI Listing Regulations ensures transparency and equal access to material information for all stakeholders. Investors rely on such disclosures to assess how corporate actions like subsidiary incorporation may influence a company’s growth trajectory, risk profile and capital allocation strategy.

While Vivacity Multiple Ventures Private Limited is yet to commence operations, its incorporation lays the foundation for future capacity creation and service expansion. Over time, the subsidiary may contribute to Nephro Care India’s revenue streams, strengthen its brand presence, and enhance its ability to offer end-to-end healthcare solutions.

In conclusion, the incorporation of Vivacity Multiple Ventures Private Limited marks a strategic step forward for Nephro Care India Limited. As highlighted in the Nephro Care India NSE filing, the company has secured a majority stake in a healthcare-focused subsidiary with a broad operational mandate. This development not only reinforces Nephro Care India’s commitment to expanding its healthcare footprint but also positions it to capitalise on emerging opportunities across diagnostics, hospitals and specialised medical services in the years ahead.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.